<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Offer</title>
<description>International Business News - Offer</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>CVS disputes investment group in Longs fight</title>
  <description>CVS Caremark Corp. said Friday it took exception to an investor's statement characterizing antitrust issues that could affect a rival bid by Walgreen Co. to buy Longs Drug Stores Corp.</description>
    <link>http://www.ibtimes.com/articles/20081003/cvs-disputes-investment-group-in-longs-fight.htm</link> 
  <pubDate>Fri, 03 Oct 2008 10:09:29 EDT</pubDate>
  </item>


  <item>
  <title>Liberty prices 4.8M share offer at $33 per share</title>
  <description>Liberty Property Trust said Thursday it will offer nearly 4.8 million shares at $33 per share. The price is a nearly 2 percent discount to the company's closing price on Thursday of $33.53.</description>
    <link>http://www.ibtimes.com/articles/20081003/liberty-prices-4-8m-share-offer-at-33-per-share.htm</link> 
  <pubDate>Fri, 03 Oct 2008 08:08:00 EDT</pubDate>
  </item>


  <item>
  <title>Kite Realty to raise $47.9M from share sale</title>
  <description>Kite Realty Group Trust priced its offering of 4.75 million shares at the below-market price of $10.55 apiece, and the real estate investment trust's existing shares tumbled past that level in morning trading Thursday.</description>
    <link>http://www.ibtimes.com/articles/20081002/kite-realty-to-raise-47-9m-from-share-sale.htm</link> 
  <pubDate>Thu, 02 Oct 2008 10:45:09 EDT</pubDate>
  </item>


  <item>
  <title>Report: ImClone's secret suitor is Eli Lilly</title>
  <description>Drugmaker Eli Lilly &amp; Co. reportedly is the secret suitor that's been courting ImClone Systems Inc. and is offering approximately $6.1 billion for the biotech company.</description>
    <link>http://www.ibtimes.com/articles/20081001/report-imclones-secret-suitor-is-eli-lilly.htm</link> 
  <pubDate>Wed, 01 Oct 2008 21:21:30 EDT</pubDate>
  </item>


  <item>
  <title>Thornburg Mortgage amends exchange offer</title>
  <description>Shares of Thornburg Mortgage Inc. surged Wednesday after the mortgage lender said it is amending its exchange offer for four classes of its preferred stock, and extending the expiration.</description>
    <link>http://www.ibtimes.com/articles/20081001/thornburg-mortgage-amends-exchange-offer.htm</link> 
  <pubDate>Wed, 01 Oct 2008 14:31:40 EDT</pubDate>
  </item>


  <item>
  <title>Germany's Merck interested, but not ImClone bidder</title>
  <description>The German drug and chemical maker Merck KGaA isn't the "white knight" suitor pursuing ImClone Systems Inc., according to the head of Merck KGaA, which has a partnership with the biotech company on cancer drug Erbitux.</description>
    <link>http://www.ibtimes.com/articles/20080930/germanys-merck-interested-but-not-imclone-bidder.htm</link> 
  <pubDate>Tue, 30 Sep 2008 12:36:19 EDT</pubDate>
  </item>


  <item>
  <title>James River completes $44 million stock offering</title>
  <description>Mine operator James River Coal has completed a 1.5 million-share stock offering. The Richmond-based company says it netted $44 million before expenses from Monday's sale.</description>
    <link>http://www.ibtimes.com/articles/20080930/james-river-completes-44-million-stock-offering.htm</link> 
  <pubDate>Tue, 30 Sep 2008 08:10:57 EDT</pubDate>
  </item>


  <item>
  <title>ImClone could name $70-a-share bidder on Wednesday</title>
  <description>ImClone Systems Inc. said Monday it expects either a solid purchase proposal or formal rejection by Wednesday night from its mystery suitor, which ImClone says is offering $70 per share for the biotech company.</description>
    <link>http://www.ibtimes.com/articles/20080929/imclone-could-name-70-a-share-bidder-on-wednesday.htm</link> 
  <pubDate>Mon, 29 Sep 2008 16:27:16 EDT</pubDate>
  </item>


  <item>
  <title>James River Coal sets offer terms</title>
  <description>Mine operator James River Coal has set the terms of a 1.5 million-share stock offering. James River says in a Securities and Exchange Commission filing Friday it's pricing the deal at $30 a share, an 11.7 percent premium to Thursday's $26.47 closing price. James River expects to net nearly $44 million after fees and expenses.</description>
    <link>http://www.ibtimes.com/articles/20080926/james-river-coal-sets-offer-terms.htm</link> 
  <pubDate>Fri, 26 Sep 2008 10:14:40 EDT</pubDate>
  </item>


  <item>
  <title>First Potomac Realty Trust prices stock offering</title>
  <description>Real estate investment trust First Potomac Realty Trust said Thursday it priced a follow-on public stock offering of 2.5 million shares at $16 per share.</description>
    <link>http://www.ibtimes.com/articles/20080925/first-potomac-realty-trust-prices-stock-offering.htm</link> 
  <pubDate>Thu, 25 Sep 2008 09:23:46 EDT</pubDate>
  </item>


  <item>
  <title>James River Coal to sell 1.5 million shares</title>
  <description>Coal producer James River Coal Co. said Wednesday it will sell 1.5 million shares with an overallotment option to sell up to an additional 225,000 shares in a public offering.</description>
    <link>http://www.ibtimes.com/articles/20080924/james-river-coal-to-sell-1-5-million-shares.htm</link> 
  <pubDate>Wed, 24 Sep 2008 09:25:42 EDT</pubDate>
  </item>


  <item>
  <title>Healthcare Realty prices new shares at $25.50</title>
  <description>Healthcare Realty Trust Inc., a real estate investment trust, said Wednesday it expects to raise $170.5 million through an offering of new stock. The company priced its 7 million shares at $25.50 per share. The underwriters of the stock offering will have the option to buy about 1.1 million in additional shares, which could bring the total proceeds to $205.3 million. The offer is expected to close Monday.</description>
    <link>http://www.ibtimes.com/articles/20080924/healthcare-realty-prices-new-shares-at-25-50.htm</link> 
  <pubDate>Wed, 24 Sep 2008 07:52:01 EDT</pubDate>
  </item>


  <item>
  <title>Longs Drug won't start sale talks with Walgreen</title>
  <description>Longs Drug Stores Corp. on Tuesday repeated its refusal to enter buyout talks with Walgreen Co., or share information with its larger rival. Longs said Walgreen "has not presented a clear roadmap to completion" of a deal, and is not willing to assume any risk that the deal is rejected or delayed by antitrust regulators.</description>
    <link>http://www.ibtimes.com/articles/20080923/longs-drug-wont-start-sale-talks-with-walgreen.htm</link> 
  <pubDate>Tue, 23 Sep 2008 17:45:03 EDT</pubDate>
  </item>


  <item>
  <title>Bristol-Myers presses ImClone; Icahn fires back</title>
  <description>ImClone Systems Inc. Chairman Carl Icahn swatted down an increased offer of $4.7 billion for his company from partner Bristol-Myers Squibb Co. Tuesday, calling it "absurd" and taunting his counterpart at the drugmaker.</description>
    <link>http://www.ibtimes.com/articles/20080923/bristol-myers-launches-sweetened-bid-for-imclone.htm</link> 
  <pubDate>Tue, 23 Sep 2008 18:06:30 EDT</pubDate>
  </item>


  <item>
  <title>Bristol-Myers boosts ImClone bid to $62 per share</title>
  <description>A rebuffed Bristol-Myers Squibb Co. boosted its buyout offer for biotech company ImClone Systems Inc. by 3 percent Monday, saying it would pay $62 per share for the portion of the company that the drug maker doesn't already own.</description>
    <link>http://www.ibtimes.com/articles/20080922/bristol-myers-boosts-imclone-bid-to-62-per-share.htm</link> 
  <pubDate>Mon, 22 Sep 2008 20:40:12 EDT</pubDate>
  </item>


  <item>
  <title>Healthcare Realty to sell new shares</title>
  <description>Healthcare Realty Trust Inc., a real estate investment trust, said Monday it will sell as many as 8.1 million new shares of stock to raise funds. The company will make an offer of 7 million shares, and underwriters will have an option to buy an additional 1.1 million shares. Healthcare Realty said it plans to use the funds to pay for recently closed and planned purchases of medical offices and other facilities, and for general corporate purposes.</description>
    <link>http://www.ibtimes.com/articles/20080922/healthcare-realty-to-sell-new-shares.htm</link> 
  <pubDate>Mon, 22 Sep 2008 13:39:18 EDT</pubDate>
  </item>


  <item>
  <title>Samsung bid for SanDisk shows memory market woes</title>
  <description>A $5.85 billion bid by Samsung Electronics Co. to take over SanDisk Corp., a wounded competitor that also serves as a partner, reflects the turbulence in the market for flash memory, a key ingredient in digital cameras, music players and other devices.</description>
    <link>http://www.ibtimes.com/articles/20080917/samsung-bid-for-sandisk-shows-memory-market-woes.htm</link> 
  <pubDate>Wed, 17 Sep 2008 16:35:06 EDT</pubDate>
  </item>


  <item>
  <title>Walgreen says it will continue Longs buyout effort</title>
  <description>Drug store operator Walgreen Co. said Wednesday it will continue to pursue Longs Drugs Stores Corp., which earlier in the day said it would not enter buyout talks with Walgreen--a move that had Longs' largest shareholder "irate."</description>
    <image>
  <url>http://www.ibtimes.com/data/articleimgs/132693-longs-drug-stores-offer.jpg</url>
  <link>http://www.ibtimes.com/articles/20080917/longs-drug-stores-rejects-walgreen-offer.htm</link>
  </image>
    <link>http://www.ibtimes.com/articles/20080917/longs-drug-stores-rejects-walgreen-offer.htm</link> 
  <pubDate>Wed, 17 Sep 2008 16:51:09 EDT</pubDate>
  </item>


  <item>
  <title>SanDisk says rejects buyout offer from Samsung</title>
  <description>SanDisk Corp. said Tuesday it had rejected a $5.85 billion takeover offer from Samsung Electronics Co. Ltd after its board determined the deal was "inadequate in multiple respects."</description>
    <link>http://www.ibtimes.com/articles/20080916/sandisk-says-rejects-buyout-offer-from-samsung.htm</link> 
  <pubDate>Tue, 16 Sep 2008 21:31:09 EDT</pubDate>
  </item>


  <item>
  <title>Bristol-Myers CFO: We could walk away from ImClone</title>
  <description>Bristol-Myers Squibb Co. might be willing to drop its quest to acquire partner biotech company ImClone Systems Inc.--under unspecified conditions. Jean-Marc Huet, who became chief financial officer at Bristol-Myers five months ago, told analysts Tuesday his company could abandon its $4.5 billion offer for the 83 percent of ImClone it doesn't already own.</description>
    <link>http://www.ibtimes.com/articles/20080916/bristol-myers-cfo-we-could-walk-away-from-imclone.htm</link> 
  <pubDate>Tue, 16 Sep 2008 17:34:52 EDT</pubDate>
  </item>


</channel>
</rss>